Crescita Therapeutics Inc.
CTX.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.50% | -303.07% | -463.97% | -321.15% | -340.53% |
| Total Depreciation and Amortization | -10.64% | -8.97% | -3.70% | 0.46% | -1.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.18% | 58.27% | -21.37% | 47.62% | 85.35% |
| Change in Net Operating Assets | 112.05% | 333.18% | 195.50% | 127.89% | 148.99% |
| Cash from Operations | 28.42% | 722.22% | 64.50% | -31.98% | 319.82% |
| Capital Expenditure | -1,458.31% | -4,338.36% | -6,788.29% | 31.64% | 45.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,400.00% | -1,619.50% | -1,265.36% | 47.93% | 56.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.09% | -7.71% | -8.95% | 69.80% | 70.28% |
| Issuance of Common Stock | -- | -100.00% | -- | 216.67% | 216.67% |
| Repurchase of Common Stock | 18.58% | -26.92% | -105.95% | -33.81% | 8.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00% | 0.00% | 0.00% | -- |
| Cash from Financing | -8.40% | -16.95% | -38.87% | 50.36% | 59.53% |
| Foreign Exchange rate Adjustments | 396.12% | -361.02% | -56.31% | -113.91% | -121.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.22% | -120.78% | -365.67% | 51.30% | 136.80% |